Evommune, Inc. EVMN
Regular-session close
After hours · Nov 19, 7:56 PM ET
- YTD
- -57.71%
- 1 year
- -62.47%
EVMN free cash flow history
Free cash flow is operating cash flow minus capital expenditure outflow. It can be negative; it is not the same as earnings.
-76,676,000 USD
FY 2025 · Period ended
Coverage: incomplete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Capital expenditure here is net of asset disposals, so free cash flow can be higher than a figure that subtracts gross purchases.
Scroll the table to see all values →
| Fiscal period | Period end | Free cash flow | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | -76,676,000 | -18,393,000 | Not meaningful |
| FY 2024 | 2024-12-31 | -58,283,000 | -28,195,000 | Not meaningful |
| FY 2023 | 2023-12-31 | -30,088,000 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-05-22T14:43:02.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.
